CPSC2019-04-25
TriDerma Recalls Pain Relief Cream Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning (Recall Alert)
TriDerma, of Corona, Calif.
Hazard
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
Remedy
Consumers should immediately store the topical anesthetic in a safe location, out of reach of children and contact TriDerma for a free replacement child-resistant cap. TriDerma is contacting all known purchasers directly.
Sold at
www.triderma.com from January 2018 through April 2019 for about $22 for the jar and about $15 for the tube.
Affected count
About 410
Injuries reported
None reported.
Manufactured in
United States
Remedy type
Replace
Products
Pain Relief Cream with Lidocaine
Consumer contact
TriDerma at 800-279-7282 from 7 a.m. to 4:30 p.m. PT Monday to Friday, email at marilyn@triderma.com or online at www.triderma.com and click on Customer Service for more information.
Official notice
https://www.cpsc.gov/Recalls/2019/TriDerma-Recalls-Pain-Relief-Cream-Due-to-Failure-to-Meet-Child-Resistant-Closure-Requirement-Risk-of-Poisoning-Recall-AlertDon't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief